Literature DB >> 22373059

A facile iodine(III)-mediated synthesis of 3-(3-aryl-1-phenyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridines via oxidation of 2-((3-aryl-1-phenyl-1H-pyrazol-4-yl)methylene)-1-(pyridin-2-yl)hydrazines and their antimicrobial evaluations.

Om Prakash1, Khalid Hussain, Deepak K Aneja, Chetan Sharma, Kamal R Aneja.   

Abstract

BACKGROUND: Fused heterocyclic 1,2,4-triazoles have acquired much importance because of their interesting biological properties. Although a number of methods have been reported in the literature which includes oxidation with phosphorus oxychloride, lead tetraacetate, bromine, etc., hypervalent iodine reagents have emerged as reagents of choice for various synthetically useful transformations due to their low toxicity, ready availability and ease of handling.
RESULTS: A series of new 3-(3-aryl-1-phenyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridines 4 has been conveniently synthesized by oxidative cyclization of 2-(3-aryl-1-phenyl-1H-pyrazol-4-yl)methylene)-1-(pyridin-2-yl)hydrazines 3 promoted with iodobenzene diacetate under mild conditions (up to 90% isolated yields). All the new compounds were tested in vitro for their antimicrobial activity.
CONCLUSIONS: Iodine(III)-mediated oxidative approach has offered an easy access to new 3-(3-aryl-1-phenyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridines 4. The antibacterial and antifungal activities of newly synthesized compounds have proved them potent antimicrobial agents.

Entities:  

Year:  2011        PMID: 22373059      PMCID: PMC3279144          DOI: 10.1186/2191-2858-1-1

Source DB:  PubMed          Journal:  Org Med Chem Lett        ISSN: 2191-2858


  17 in total

1.  Antimicrobial and phytochemical studies on 45 Indian medicinal plants against multi-drug resistant human pathogens.

Authors:  I Ahmad; A Z Beg
Journal:  J Ethnopharmacol       Date:  2001-02       Impact factor: 4.360

2.  The effect of 1,3-diaryl-[1H]-pyrazole-4-acetamides on glucose utilization in ob/ob mice.

Authors:  G R Bebernitz; G Argentieri; B Battle; C Brennan; B Balkan; B F Burkey; M Eckhardt; J Gao; P Kapa; R J Strohschein; H F Schuster; M Wilson; D D Xu
Journal:  J Med Chem       Date:  2001-08-02       Impact factor: 7.446

3.  Benzimidazolyl-1,2,4(H)-triazoles as central nervous system depressants.

Authors:  S S Parmar; A K Gupta; H H Singh; T K Gupta
Journal:  J Med Chem       Date:  1972-09       Impact factor: 7.446

4.  4-[3(5)-pyrazolyl]pyridinium salts. A new class of hypoglycemic agents.

Authors:  V J Bauer; H P Dalalian; W J Fanshawe; S R Safir
Journal:  J Med Chem       Date:  1968-09       Impact factor: 7.446

5.  Evaluation of extracts of the root of Landolphia owerrience for antibacterial activity.

Authors:  M I Okeke; C U Iroegbu; E N Eze; A S Okoli; C O Esimone
Journal:  J Ethnopharmacol       Date:  2001-12       Impact factor: 4.360

6.  Novel 1,5-diphenylpyrazole nonnucleoside HIV-1 reverse transcriptase inhibitors with enhanced activity versus the delavirdine-resistant P236L mutant: lead identification and SAR of 3- and 4-substituted derivatives.

Authors:  M J Genin; C Biles; B J Keiser; S M Poppe; S M Swaney; W G Tarpley; Y Yagi; D L Romero
Journal:  J Med Chem       Date:  2000-03-09       Impact factor: 7.446

7.  Chemical composition, antibacterial and antifungal activities of the essential oil of Haplophyllum tuberculatum from Oman.

Authors:  Suad Khamis S Al-Burtamani; Majekodunmi O Fatope; Ruchi G Marwah; Anthony K Onifade; Salim H Al-Saidi
Journal:  J Ethnopharmacol       Date:  2005-01-04       Impact factor: 4.360

8.  Synthesis, crystal structure, magnetic properties, and theoretical studies of [(Cu(mepirizole)Br)2(mu-OH)(mu-pz)] (mepirizole=4-methoxy-2-(5-methoxy-3-methyl-1H-pyrazol-1-yl)-6-methylpyrimidine; pz=pyrazolate), a novel mu-pyrazolato-mu-hydroxo-dibridged copper(II) complex.

Authors:  Emilio Escrivà; Julia García-Lozano; José Martínez-Lillo; Hugo Nuñez; Juan Server-Carrió; Lucía Soto; Rosa Carrasco; Joan Cano
Journal:  Inorg Chem       Date:  2003-12-15       Impact factor: 5.165

9.  Synthesis and molecular structure of 6-amino-3-benzylmercapto-1,2,4-triazolo[3,4-f][1,2,4]triazin-8(7H)-one.

Authors:  Long-Chih Hwang; Chun-Hsie Tu; Jung-Hui Wang; Gene-Hsiang Lee
Journal:  Molecules       Date:  2006-03-17       Impact factor: 4.411

10.  Hypervalent iodine mediated synthesis of 1-aryl/hetryl-1,2,4-triazolo[4,3-a] pyridines and 1-aryl/hetryl 5-methyl-1,2,4-triazolo[4,3-a]quinolines as antibacterial agents.

Authors:  Anil K Sadana; Yasmin Mirza; Kamal R Aneja; Om Prakash
Journal:  Eur J Med Chem       Date:  2003-05       Impact factor: 6.514

View more
  4 in total

1.  Design and synthesis of novel (Z)-5-((1,3-diphenyl-1H-pyrazol-4-yl)methylene)-3-((1-substituted phenyl-1H-1,2,3-triazol-4-yl)methyl)thiazolidine-2,4-diones: a potential cytotoxic scaffolds and their molecular modeling studies.

Authors:  N J P Subhashini; Kolluri Prashanth Kumar; Edigi Praveen Kumar; Putta Shravani; Surya Sathyanarayana Singh; Tamalapakula Vani; Manga Vijjulatha
Journal:  Mol Divers       Date:  2020-05-02       Impact factor: 2.943

2.  The Structural and Optical Properties of 1,2,4-Triazolo[4,3-a]pyridine-3-amine.

Authors:  Lucyna Dymińska; Jerzy Hanuza; Jan Janczak; Maciej Ptak; Radosław Lisiecki
Journal:  Molecules       Date:  2022-01-22       Impact factor: 4.411

3.  Synthesis, Molecular Docking and in Vitro Screening of Some Newly Synthesized Triazolopyridine, Pyridotriazine and Pyridine⁻Pyrazole Hybrid Derivatives.

Authors:  Eman M Flefel; Walaa I El-Sofany; Mahmoud El-Shahat; Arshi Naqvi; Eman Assirey
Journal:  Molecules       Date:  2018-10-06       Impact factor: 4.411

4.  A Novel Series of [1,2,4]Triazolo[4,3-a]Pyridine Sulfonamides as Potential Antimalarial Agents: In Silico Studies, Synthesis and In Vitro Evaluation.

Authors:  Veronika R Karpina; Svitlana S Kovalenko; Sergiy M Kovalenko; Oleksandr G Drushlyak; Natalya D Bunyatyan; Victoriya A Georgiyants; Vladimir V Ivanov; Thierry Langer; Louis Maes
Journal:  Molecules       Date:  2020-09-30       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.